Tower Research Capital LLC (Trc) Dynavax Technologies Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 16,873 shares of DVAX stock, worth $213,105. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,873
Previous 52,349
67.77%
Holding current value
$213,105
Previous $587,000
68.14%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding DVAX
# of Institutions
273Shares Held
130MCall Options Held
451KPut Options Held
203K-
Black Rock Inc. New York, NY21.9MShares$277 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$158 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.22MShares$116 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.33MShares$105 Million7.62% of portfolio
-
State Street Corp Boston, MA7.69MShares$97.1 Million0.0% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.6B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...